Suppressor cells in demyelinating disease: A new paradigm for the new millennium

Journal of Neuroimmunology

Volumn 100, Issue 1-2, 1999, Pages 53-57

  Lenz, Derek C ^a   Swanborg, Robert H ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Experimental autoimmune encephalomyelitis; Natural killer cell; Suppressor T cell

Indexed keywords

CYTOKINE; FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 5; MYELIN; MYELIN BASIC PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; APOPTOSIS; ARTICLE; CYTOTOXICITY; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; MOUSE; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SUPPRESSOR CELL;

ANIMALS; APOPTOSIS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; KILLER CELLS, NATURAL; MULTIPLE SCLEROSIS; RATS; RATS, INBRED LEW; T-LYMPHOCYTES, REGULATORY; TIME FACTORS;

EID: 0033375606     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00208-8     Document Type: Article

References (40)

1. Abbas A.K. Die and let live: eliminating dangerous lymphocytes. Cell. 84:1996;655-657.
2. Adda D.-H., Beraud E., Depieds R. Evidence for suppressor cells in Lewis rats' experimental allergic encephalomyelitis. Eur. J. Immunol. 7:1977;620-623.
3. Alvord E.C. Jr., Shaw C.-M., Hruby S., Kies M.W. Encephalitogen-induced inhibition of experimental allergic encephalomyelitis: prevention, suppression and therapy. Ann. N. Y. Acad. Sci. 122:1965;333-345.
4. Barzaga-Gilbert M.M., Skeen M.J., Chou C.H.J., Fritz R.B. Suppressive activity of long-term myelin basic protein-specific SJL T cell lines. J. Neuroimmunol. 23:1989;241-247.
5. Bernard C.C.A. Suppressor T cells prevent experimental autoimmune encephalomyelitis in mice. Clin. Exp. Immunol. 29:1977;100-109.
6. Bornstein M.B., Miller A., Slagle S., Weitzman M., Crystal H., Drexler E., Keilson M., Merriam A., Wassertheil-Smoller S., Spada V., Weiss W., Arnon R., Jacobsohn I., Teitelbaum D., Sela M. A pilot trial of Cop I in exacerbating-remitting multiple sclerosis. N. Engl. J. Med. 317:1987;408-414.
7. Brocke S., Gijbels K., Allegretta M., Ferber I., Piercy C., Blankenstein T., Martin R., Utz U., Karin N., Mitchell D., Veromaa T., Waisman A., Gaur A., Conlon P., Ling N., Fairchild P.J., Wraith D.C., O'Garra A., Fathman C.G., Steinman L. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature. 379:1996;343-346.
8. Chen Y., Kuchroo V.K., Inobe J.-I., Hafler D.A., Weiner H.L. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science. 265:1994;237-240.
9. Falcone M., Bloom B.R. A T helper cell 2 (Th2) immune response against non-self antigens modifies the cytokine profile of autoimmune T cells and protects against experimental allergic encephalomyelitis. J. Exp. Med. 185:1997;901-907.
10. Ferraro A., Cazzullo C.L. Prevention of experimental allergic encephalomyelitis in guinea pigs. J. Neuropathol. Exp. Neurol. 8:1949;61-69.
11. Forsthuber T., Yip H.C., Lehmann P.V. Induction of Th1 and Th2 immunity in neonatal mice. Science. 271:1996;1728-1730.
12. Gershon R.K., Kondo K. Infectious immunological tolerance. Immunology. 21:1971;903-914.
13. Green D.R., Flood P.M., Gershon R.K. Immunoregulatory T cell pathways. Annu. Rev. Immunol. 1:1983;439-463.
14. Ishigami T., White C.A., Pender M.P. Soluble antigen therapy induces apoptosis of autoreactive T cells preferentially in the target organ rather than in the peripheral lymphoid organs. Eur. J. Immunol. 28:1998;1626-1635.
15. Karpus W.J., Swanborg R.H. CD4+ suppressor cells differentially affect the production of IFN-gamma by effector cells of experimental autoimmune encephalomyelitis. J. Immunol. 143:1989;3492-3497.
16. Karpus W.J., Swanborg R.H. CD4+ suppressor cells inhibit the function of effector cells of experimental autoimmune encephalomyelitis through a mechanism involving transforming growth factor-beta. J. Immunol. 146:1991;1163-1168.
17. + suppressor cells of autoimmune encephalomyelitis respond to TCR-associated determinants on effector cells by IL-4 secretion. Eur. J. Immunol. 22:1992;1757-1763.
18. Karussis D.M., Lehmann D., Slavin S., Vourka-Karussis U., Mizrachi-Koll R., Ovadia H., Ben-Nun A., Kalland T., Abramsky O. Inhibition of acute experimental autoimmune encephalomyelitis by the synthetic immunomodulator Linomide. Ann. Neurol. 34:1993;654-660.
19. Körner H., Sedgwick J.D. Tumour necrosis factor and lymphotoxin: molecular aspects and role in tissue-specific autoimmunity. Immunol. Cell Biol. 74:1996;465-472.
20. Kumar V., Sercarz E.E. The involvement of T cell receptor peptide-specific regulatory CD4+ T cells in recovery from antigen-induced autoimmune disease. J. Exp. Med. 178:1993;909-916.
21. Lanier L.L. NK cell receptors. Annu. Rev. Immunol. 16:1998;359-393.
22. Lenz D.C., Wolf N.A., Swanborg R.H. Strain variations in autoimmunity: attempted tolerization of DA rats results in the induction of experimental autoimmune encephalomyelitis. J. Immunol. 163:1999;1763-1768.
23. Matsumoto Y., Kohyama K., Aikawa Y., Shin T., Kawazoe Y., Suzuki Y., Tanuma N. Role of natural killer cells and TCRgd T cells in acute autoimmune encephalomyelitis. Eur. J. Immunol. 28:1998;1681-1688.
24. Morimoto C., Hafler D.A., Weiner H.L., Letvin N.L., Hagan M., Daley J., Schlossman S.F. Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis. Analysis with anti-2H4 monoclonal antibody. N. Engl. J. Med. 316:1987;67-72.
25. Offner H., Vainiene M., Celnik B., Weinberg A.D., Buenafe A., Vandenbark A.A. Coculture of TCR peptide-specific T cells with basic protein-specific T cells inhibits proliferation, IL-3 mRNA, and transfer of experimental autoimmune encephalomyelitis. J. Immunol. 153:1994;4988-4996.
26. Oshimi Y., Oda S., Honda Y., Nagata S., Miyazaki S. Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells. J. Immunol. 157:1996;2909-2915.
27. Sabelko-Downes K.A., Cross A.H., Russell J.H. Dual role for Fas ligand in the initiation and recovery from experimental allergic encephalomyelitis. J. Exp. Med. 189:1999;1195-1205.
28. Smeltz R.B., Wolf N.A., Swanborg R.H. Inhibition of autoimmune T cell responses in the DA rat by bone marrow-derived natural killer cells in vitro: implications for autoimmunity. J. Immunol. 163:1999;1390-1398.
29. Stevens D.B., Gould K.E., Swanborg R.H. Transforming growth factor-b1 inhibits tumor necrosis factor-a/lymphotoxin production and adoptive transfer of disease by effector cells of autoimmune encephalomyelitis. J. Neuroimmunol. 51:1994;77-83.
30. Sun D., Qin Y., Chluba J., Epplen J.T., Wekerle H. Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T cell interactions. Nature. 332:1988;843-845.
31. Svet-Moldavskaya I.A., Svet-Moldavsky G.J. Acquired resistance to experimental allergic encephalomyelitis. Nature. 181:1958;1536-1537.
32. Swanborg R.H. Antigen-induced inhibition of experimental allergic encephalomyelitis: I. Inhibition in guinea pigs injected with non-encephalitogenic modified myelin basic protein. J. Immunol. 109:1972;540-546.
33. Swanborg R.H. Antigen-induced inhibition of experimental allergic encephalomyelitis: III. Localization of an inhibitory site distinct from the major encephalitogenic determinant of myelin basic protein. J. Immunol. 114:1975;191-194.
34. Swierkosz J.E., Swanborg R.H. Suppressor cell control of unresponsiveness to experimental allergic encephalomyelitis. J. Immunol. 115:1975;631-633.
35. Swierkosz J.E., Swanborg R.H. Immunoregulation of experimental allergic encephalomyelitis: conditions for induction of suppressor cells and analysis of mechanism. J. Immunol. 119:1977;1501-1506.
36. Teitelbaum D., Meshorer A., Hirshfeld T., Arnon R., Sela M. Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide. Eur. J. Immunol. 1:1971;242-248.
37. Welch A.M., Holda J.H., Swanborg R.H. Regulation of experimental allergic encephalomyelitis: II. Appearance of suppressor cells during the remission phase of the disease. J. Immunol. 125:1980;186-189.
38. White C.A., McCombe P.A., Pender M.P. The roles of Fas, Fas ligand and Bcl-2 in T cell apoptosis in the central nervous system in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 82:1998;47-55.
39. Willenborg D.O. Experimental allergic encephalomyelitis in the Lewis rat: studies on the mechanism of recovery from disease and acquired resistance to reinduction. J. Immunol. 123:1979;1145-1150.
40. Zhang B., Yamamura T., Kondo T., Fujiwara M., Tabira T. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J. Exp. Med. 186:1997;1677-1687.